AXM Pharma, Inc. (AXMP)

AXM Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2017	FY 2005
Period Ending	Dec 31, 2017	Dec 31, 2005
Revenue	113.08	2.02
Revenue Growth (YoY)	5493.37%	-
Cost of Revenue	93	-
Gross Profit	20.08	0.77
Selling, General & Admin	5.3	-
Other Operating Expenses	0.68	-
Operating Expenses	5.98	-
Operating Income	14.11	-
Interest Expense	-0.73	-
Other Non Operating Income (Expenses)	-1.16	-
Pretax Income	12.21	-
Income Tax Expense	4.03	-
Earnings From Continuing Operations	8.18	-
Net Income	8.18	-11.09
Net Income to Common	8.18	-
Shares Outstanding (Basic)	5,300	-
Shares Outstanding (Diluted)	5,300	-
EPS (Basic)	0.00	-
EPS (Diluted)	0.00	-
Free Cash Flow	13.14	-
Free Cash Flow Per Share	0.00	-
Gross Margin	17.76%	38.20%
Operating Margin	12.47%	-
Profit Margin	7.23%	-
Free Cash Flow Margin	11.62%	-
EBITDA	15.27	-
EBITDA Margin	13.50%	-
D&A For EBITDA	1.16	-
EBIT	14.11	-
EBIT Margin	12.47%	-
Effective Tax Rate	33.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.